Galderma approved for Differin(R) Gel 0.1 percent in Japan

July 17, 2008

Lausanne, Switzerland - Galderma Pharma S.A. announced that Japan’s Health Labor and Welfare has approved Differin(R) Gel 0.1 percent (adapalene).

Lausanne, Switzerland

- Galderma Pharma S.A. announced that Japan’s Health Labor and Welfare has approved Differin(R) Gel 0.1 percent (adapalene).

The drug, used to treat acne vulgaris, will be marketed in Japan by Galderma KK, the Japanese arm of Galderma.